Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
CALL
Ferguson
FERG
$47.4B
| $7.04M | ﹤0.01% |
+63,600
| New | +$7.7M |
|
3102
Core Alternative Capital
CCOR
$28.2M
| $7.04M | ﹤0.01% |
+229,514
| New | +$6.97M |
|
|
SAFM
3103
DELISTED
Sanderson Farms Inc
SAFM
| $7.03M | ﹤0.01% |
32,638
-4,715
| -13% | -$923K |
|
3104
Leslie's
LESL
$6.04M
| $7.03M | ﹤0.01% |
23,146
-9,974
| -30% | -$3.72M |
|
3105
Warby Parker
WRBY
$3.2B
| $7.02M | ﹤0.01% |
623,793
+346,574
| +125% | +$6.96M |
|
3106
abrdn Physical Palladium Shares ETF
PALL
$651M
| $7.02M | ﹤0.01% |
196,550
+190,615
| +3,212% | +$7.39M |
|
3107
CALL
Neurocrine Biosciences
NBIX
$15.5B
| $7.02M | ﹤0.01% |
72,000
+18,400
| +34% | +$1.7M |
|
3108
Assured Guaranty
AGO
$3.38B
| $7.01M | ﹤0.01% |
125,740
+16,079
| +15% | +$928K |
|
|
VTNR
3109
PUT
DELISTED
Vertex Energy, Inc
VTNR
| $7.01M | ﹤0.01% |
666,700
+292,300
| +78% | +$3.46M |
|
3110
Anavex Life Sciences
AVXL
$298M
| $7M | ﹤0.01% |
699,719
+471,144
| +206% | +$4.46M |
|
3111
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.78B
| $7M | ﹤0.01% |
131,385
-266,842
| -67% | -$14.8M |
|
3112
CALL
Lattice Semiconductor
LSCC
$18.5B
| $7M | ﹤0.01% |
144,400
-113,300
| -44% | -$5.64M |
|
3113
CALL
InMode
INMD
$872M
| $7M | ﹤0.01% |
312,300
-9,100
| -3% | -$239K |
|
3114
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.74B
| $6.99M | ﹤0.01% |
234,958
+203,716
| +652% | +$6.43M |
|
|
MFA
3115
CALL
MFA Financial
MFA
$926M
| $6.99M | ﹤0.01% |
650,150
-23,750
| -4% | -$320K |
|
3116
PUT
Shake Shack
SHAK
$3.02B
| $6.99M | ﹤0.01% |
177,000
+48,400
| +38% | +$2.47M |
|
|
DALS
3117
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
| $6.99M | ﹤0.01% |
720,941
+125,000
| +21% | +$1.22M |
|
|
USAK
3118
DELISTED
USA Truck Inc
USAK
| $6.97M | ﹤0.01% |
221,853
+196,196
| +765% | +$3.38M |
|
3119
Customers Bancorp
CUBI
$2.82B
| $6.96M | ﹤0.01% |
205,309
+126,367
| +160% | +$5.14M |
|
|
MRC
3120
DELISTED
MRC Global
MRC
| $6.95M | ﹤0.01% |
697,543
-207,904
| -23% | -$2.31M |
|
3121
CALL
Madison Square Garden
MSGS
$9.8B
| $6.95M | ﹤0.01% |
46,000
+3,500
| +8% | +$568K |
|
3122
PUT
Kulicke & Soffa
KLIC
$5.19B
| $6.94M | ﹤0.01% |
162,200
+107,500
| +197% | +$5.32M |
|
|
RETA
3123
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $6.94M | ﹤0.01% |
228,503
+99,660
| +77% | +$2.97M |
|
3124
Capitol Federal Financial
CFFN
$1.08B
| $6.93M | ﹤0.01% |
754,987
+205,010
| +37% | +$2.03M |
|
3125
Ocular Therapeutix
OCUL
$2.2B
| $6.93M | ﹤0.01% |
1,723,993
+31,657
| +2% | +$120K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.